Verrica Pharmaceuticals Appoints Diem Nguyen, Ph.D., M.B.A., to its Board of Directors
June 10, 2020 07:30 ET
|
Verrica Pharmaceuticals Inc.
– Global biopharmaceutical industry veteran brings significant commercial expertise and business acumen to help advance the Company’s medical dermatology portfolio – WEST CHESTER, Penn., June ...
Verrica Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference
May 27, 2020 07:30 ET
|
Verrica Pharmaceuticals Inc.
WEST CHESTER, Pa., May 27, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases...
Verrica Pharmaceuticals Reports First Quarter 2020 Financial Results
May 07, 2020 07:00 ET
|
Verrica Pharmaceuticals Inc.
- Secured $55 million in non-dilutive loan facilities, of which $35 million was borrowed upon closing - - Continued to prepare for potential U.S. approval of VP-102 for the treatment of molluscum...
Verrica Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference and the RBC Capital Markets Global Healthcare Conference
May 06, 2020 07:05 ET
|
Verrica Pharmaceuticals Inc.
WEST CHESTER, Pa., May 06, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases...
Verrica Pharmaceuticals to Participate in the 19th Annual Needham Virtual Healthcare Conference
April 09, 2020 16:05 ET
|
Verrica Pharmaceuticals Inc.
WEST CHESTER, Pa., April 09, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases...
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results
March 13, 2020 07:00 ET
|
Verrica Pharmaceuticals Inc.
- New Drug Application for VP-102 for the treatment of molluscum contagiosum was accepted for filing by the U.S. Food and Drug Administration; assigned PDUFA goal date is July 13, 2020 - - Recently...
Verrica Pharmaceuticals Secures $55 Million in Loan Facilities Led by Silicon Valley Bank
March 11, 2020 07:00 ET
|
Verrica Pharmaceuticals Inc.
WEST CHESTER, Pa., March 11, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases...
Verrica Pharmaceuticals to Attend Several Upcoming Investor Conferences
February 20, 2020 09:45 ET
|
Verrica Pharmaceuticals Inc.
WEST CHESTER, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases...
Verrica Pharmaceuticals Announces the Hiring of Two Vice Presidents to Further Grow its Commercial Capabilities
January 29, 2020 07:00 ET
|
Verrica Pharmaceuticals Inc.
– Gerard DiGirolamo joins as Vice President, Sales,and Sheila Kennedy joins as Vice President, Marketing – – Extensive expertise and deep relationships in dermatology therapeutics will support...
Verrica Pharmaceuticals Announces Presentation of Positive Data from New Pooled Analysis of Phase 3 CAMP Trials of VP-102
January 18, 2020 10:00 ET
|
Verrica Pharmaceuticals Inc.
- Analysis suggested statistically significantly higher lesion clearance with VP-102 compared to vehicle in all regions of the body, including those deemed most sensitive - - If approved, VP-102...